When Icra revised the rating earlier this year, the fear was that a shutdown in China prompted by the Covid-19 pandemic would block key active pharmaceutical ingredients (APIs) from coming into the country. APIs are the basic ingredients for drugs.from Industry-Economic Times
Read The Rest:economictimes...
